Orotic acid-13C,15N2 (monohydrate) - HY-N0157S1
Catalog #
HY-N0157S1
641,00 €
Orotic acid-13C,15N2 (monohydrate) is the 13C and 15N labeled Orotic acid[1]. Orotic acid (6-Carboxyuracil), a precursor in biosynthesis of pyrimidine nucleotides and RNA, is released from the mitochondrial dihydroorotate dehydrogenase (DHODH) for conversion to UMP by the cytoplasmic UMP synthase enzyme. Orotic acid is a marker for measurement in routine newborn screening for urea cycle disorders. Orotic acid can induce hepatic steatosis and hepatomegaly in rats[2][3][4].
| Datasheet URL | http://file.medchemexpress.com/batch_PDF/HY-N0157S1/Orotic-acid-13C-15N2-monohydrate-DataSheet-MedChemExpress.pdf |
|---|---|
| Quantity | 1mg |
| Shipping | Room Temperature |
| Application | Metabolism-protein/nucleotide metabolism |
| Alternative Names | 6-Carboxyuracil-13C,15N2 (monohydrate); Vitamin B13-13C,15N2 (monohydrate) |
| CAS | 1346602-15-0 |
| Storage | 4°C (Powder, sealed storage, away from moisture) |
| MWT | 177.09 |
| Solubility | DMSO : 55 mg/mL (ultrasonic;warming) |
| Clinical Information | No Development Reported |
| Target | Endogenous Metabolite;Nucleoside Antimetabolite/Analog |
| Application: | Metabolism-protein/nucleotide metabolism |
|---|